易明医药: 第三届董事会第二十七次临时会议决议公告

Group 1 - The company held its 27th temporary board meeting on September 2, 2025, to conduct the board member election process as the current term has expired [1][2] - The fourth board will consist of 7 members, including 3 independent directors, 3 non-independent directors, and 1 employee director [1] - The board proposed the election of three non-independent directors: Fu Lihua, Huang Lingyi, and Yao Yan, with unanimous approval from all 7 attending board members [2][3] Group 2 - The board also proposed the election of three independent directors: He Deming, Chen Yan, and Wang Guangying, with unanimous approval from all 7 attending board members [3][9] - The independent director candidates have met the qualifications required by the Shenzhen Stock Exchange and will be submitted for approval at the upcoming shareholder meeting [3][9] - The fourth independent directors' term will last for three years starting from the date of election approval at the shareholder meeting [3][9] Group 3 - The company plans to hold the 2025 second temporary shareholder meeting on September 19, 2025, at 14:00 [4] - The meeting will include the election of the new board members using a cumulative voting system [4] - The resumes of the nominated candidates for both independent and non-independent directors are attached for reference [4][8]